scholarly journals Hypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study

2017 ◽  
Vol 30 (12) ◽  
pp. 1284-1291 ◽  
Author(s):  
Xavier Matillon ◽  
Fabrice Danjou ◽  
Palmina Petruzzo ◽  
Olivier Thaunat ◽  
Thomas Rimmele ◽  
...  
CHEST Journal ◽  
2014 ◽  
Vol 145 (3) ◽  
pp. 207C
Author(s):  
Sumedh Hoskote ◽  
Elizabeth Hassebroek ◽  
Shihab Sugeir ◽  
Sumanjit Kaur ◽  
Aysen Erdogan ◽  
...  

2021 ◽  
Author(s):  
Ester Elisabet Holmström ◽  
Ilmar Efendijev ◽  
Rahul Raj ◽  
Pirkka T. Pekkarinen ◽  
Erik Litonius ◽  
...  

Abstract Background: Cardiac arrest (CA) is a leading cause of death worldwide. As population ages, the need for research focusing on CA in elderly increases. This study investigated treatment intensity, 12-month neurological outcome, mortality and healthcare-associated costs for patients aged over 75 years treated for CA in an intensive care unit (ICU) of a tertiary hospital. Methods: This single-centre retrospective study included adult CA patients treated in a Finnish tertiary hospital’s ICU between 2005 and 2013. We stratified the study population into two age groups: <75 and 75 years. We compared interventions defined by the median daily therapeutic scoring system (TISS-76) between the age groups to find differences in treatment intensity. We calculated cost-effectiveness by dividing the total one-year healthcare-associated costs of all patients by the number of survivors with a favourable neurological outcome. Favourable outcome was defined as a cerebral performance category (CPC) of 1–2 at 12 months after cardiac arrest. Logistic regression analysis was used to identify independent association between age group, mortality and neurological outcome. Results: This study included a total of 1,285 patients, of which 212 (16%) were 75 years of age. Treatment intensity was lower for the elderly compared to the younger group, with median TISS scores of 116 and 147, respectively (p < 0.001). The effective cost in euros for patients with a good one-year neurological outcome was €168,000 for the elderly and €120,000 for the younger group. At 12 months after CA 24% of the patients in the elderly group and 47% of the patients in the younger group had a CPC of 1-2 (p < 0.001). Age was an independent predictor of mortality (multivariate OR = 3.36, 95% CI:2.21-5.11, p < 0.001) and neurological outcome (multivariate OR = 3.27, 95% CI: 2.12-5.03, p < 0.001). Conclusions: The elderly ICU-treated CA patients in this study had worse neurological outcomes, higher mortality and lower cost-effectiveness than younger patients. Further efforts are needed to recognize the tools for assessing which elderly patients benefit from a more aggressive treatment approach in order to improve the cost-effectiveness of post-CA management.


2019 ◽  
Vol 7 (28) ◽  
pp. 7-17
Author(s):  
Daniel Cordoba ◽  
Eneko Larumbe ◽  
Brittany Rosales ◽  
Kenneth Nugent

Objective: To better delineate the benefits and risks of systemic thrombolytic therapy inpatients with cardiac arrest from non-traumatic etiologies.Data sources: MEDLINE, EMBASE, and SCOPUS were systematically searched up toNovember of 2017.Study Selection: All retrospective and prospective studies in which systemic thrombolytictherapy was used during the sequence of cardiopulmonary resuscitation (CPR) or shortly afterachieving return of spontaneous circulation (ROSC) were included.Data extraction: The following variable results were extracted from intervention and controlgroups if available: rate of ROSC, survival after 24 hours, survival at discharge, neurologicalperformance at 6 months based on a favorable Cerebral Performance Categories Scale (1 or 2)and major bleeding events.Data Synthesis: Eight retrospective studies and 6 prospective studies were included in thequalitative analysis. Research synthesis was conducted when at least 4 studies were availablefor an outcome, which limited the analysis of major bleeding events and neurologic outcomes.Benefit of thrombolytic therapy in survival to discharge showed a moderate beneficial effect(OR = 2.79, 2.11–3.69) in the retrospective study analysis while in the prospective study analysisno statistically significant benefit was found (OR = 1.27, 0.77–2.10). Benefit of thrombolysis inthe rate of ROSC was not statistically significant in the prospective analysis (OR = 1.59, 0.92–2.76, p = 0.138) as well as survival at 24 hours (OR = 1.17, 0.72–1.71).Conclusions: The widespread use of thrombolytics in patients with non-traumatic cardiacarrest does not seem to improve major outcomes, including survival to discharge. However,the modest benefit found in the retrospective study analysis suggests a subgroup of patientsthat may benefit from this therapy.


Circulation ◽  
2020 ◽  
Vol 142 (Suppl_4) ◽  
Author(s):  
Changshin Kang

Aim: In a previous study, low and high-normal arterial carbon dioxide tension (PaCO 2 ) were not associated with serum neuron specific enolase (NSE) in cardiac arrest survivors. We assessed the effect of PaCO 2 on NSE in cerebrospinal fluid (CSF) and serum. Methods: This was a retrospective study. PaCO 2 for the first 24 h was analysed in four means, qualitative exposure state (qES), time-weighted average (TWA), median, and minimum-maximum (Min-Max). These subgroups were divided into low (LCO 2 ) and high PaCO 2 (HCO 2 ) groups defined as PaCO 2 ≤35.3 and PaCO 2 >43.5 mmHg, respectively. NSE was measured at 24, 48, and 72 h (sNSE 24,48,72 and cNSE 24,48,72 ) from return of spontaneous circulation (ROSC). The primary outcome was the association between PaCO 2 and the NSE measured at 24 h after ROSC. Results: Forty-two subjects (male, 33; 78.6%) were included in total cohort. PaCO 2 in TWA subgroup was associated with cNSE 24,48,72 , while PaCO 2 in the other subgroup were only associated with cNSE 24 . PaCO 2 and cNSE in qES subgroup showed good correlation (r= -0.61; p< 0.01), and in TWA, Median, and Min-Max subgroup showed moderate correlations (r= -0.57, r= -0.48, and r= -0.60; p< 0.01). Contrastively, sNSE was not associated and correlated with PaCO 2 in all analysis. Poor neurological outcome in LCO 2 was significantly higher than HCO 2 in qES, TWA, and Median subgroups ( p< 0.01, p< 0.01, and p= 0.02). Conclusion: Association was found between NSE and PaCO 2 using CSF, despite including normocapnic ranges; TWA of PaCO 2 may be most strongly associated with CSF NSE levels. A prospective, multi-centre study is required to confirm our results.


Resuscitation ◽  
2020 ◽  
Vol 154 ◽  
pp. 19-24
Author(s):  
Daniel Jost ◽  
Vivien Hong Tuan Ha ◽  
Julie Trichereau ◽  
Benoit Frattini ◽  
Clément Derkenne ◽  
...  

2013 ◽  
Vol 45 (1) ◽  
pp. 57-64 ◽  
Author(s):  
Shunsuke Takaki ◽  
Yoshinori Kamiya ◽  
Yoshio Tahara ◽  
Masahumi Tou ◽  
Akira Shimoyama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document